Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 1
2009 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Management of Oligometastatic Breast Cancer: An Expert Committee's Opinion.
Leblanc D, Cantin G, Desnoyers A, Dufresne J, Masucci GL, Panet-Raymond V, Poirier É, Soldera S, Gingras I. Leblanc D, et al. Among authors: panet raymond v. Curr Oncol. 2023 Jan 19;30(2):1416-1425. doi: 10.3390/curroncol30020108. Curr Oncol. 2023. PMID: 36826069 Free PMC article.
Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy.
Cohen V, Panet-Raymond V, Sabbaghian N, Morin I, Batist G, Rozen R. Cohen V, et al. Among authors: panet raymond v. Clin Cancer Res. 2003 May;9(5):1611-5. Clin Cancer Res. 2003. PMID: 12738713
EXPERIMENTAL DESIGN: Forty-three patients with metastatic colorectal adenocarcinoma were analyzed. All patients were treated with p.o. or i.v. fluoropyrimidine-based chemotherapy. A comprehensive chart examination was performed to determine tumor response rates. ...
EXPERIMENTAL DESIGN: Forty-three patients with metastatic colorectal adenocarcinoma were analyzed. All patients were treated with p.o. or i. …
Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.
Panet-Raymond V, Souhami L, Roberge D, Kavan P, Shakibnia L, Muanza T, Lambert C, Leblanc R, Del Maestro R, Guiot MC, Shenouda G. Panet-Raymond V, et al. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):473-8. doi: 10.1016/j.ijrobp.2008.04.030. Epub 2008 Jun 12. Int J Radiat Oncol Biol Phys. 2009. PMID: 18554821
Despite a high number of patients with poor prognostic features (74.3% recursive partitioning analysis class V or VI), the median survival was comparable to that after standard radiotherapy fractionation schedules plus TMZ....
Despite a high number of patients with poor prognostic features (74.3% recursive partitioning analysis class V or VI), the median sur …